- $1.89bn
- $1.67bn
- $226.47m
- 60
- 10
- 54
- 37
Annual income statement for Ambarella, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 229 | 223 | 332 | 338 | 226 |
| Cost of Revenue | |||||
| Gross Profit | 133 | 136 | 208 | 209 | 137 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 278 | 284 | 361 | 412 | 381 |
| Operating Profit | -49.6 | -61.2 | -29.6 | -74.3 | -155 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -41.6 | -57.3 | -28.6 | -70.9 | -149 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -44.8 | -59.8 | -26.4 | -65.4 | -169 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -44.8 | -59.8 | -26.4 | -65.4 | -169 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -44.8 | -59.8 | -26.4 | -65.4 | -169 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.35 | -1.72 | -0.655 | -1.65 | -4.25 |